Diabetes Reversal Company Breathe Well-being Raises INR 50 Crore In Pre-Series B Funding The company will use the funds to strengthen its coaching academy, expand the core team, and scale up the technology platform to enhance customer experience

By Teena Jose

Opinions expressed by Entrepreneur contributors are their own.

You're reading Entrepreneur India, an international franchise of Entrepreneur Media.

Company handout

Diabetes Reversal company Breathe Well-being has raised INR 50 crores in a pre-Series B round co-led by 3One4 Capital, Accel and General Catalyst. The round also saw participation from FounderBank Capital and Supermorpheus. The company will use the funds to strengthen its coaching academy, expand the core team, and scale up the technology platform to enhance customer experience.

"India is the diabetes capital of the world and we are on a mission to change that. Our aim is a Diabetes Mukt Bharat (Diabetes Free India) with the aim to reverse diabetes for 1 million Indians by 2025 and we are well on track to achieve that goal. Referral is our strongest growth lever especially in non-metros and more than half our customers come through word of mouth," said Rohan Verma, co-founder and CEO, Breathe Well-being.

India's first clinically-proven Diabetes Reversal Program by Breathe helps reduce HbA1c levels, lose weight, improve glucose tolerance and stop diabetes medication eventually. Their program has a proven outcome with 95%+ participants showing an average reduction of 1.5% in their HbA1c levels, 98%+ participants eliminating medication and experiencing an average weight loss of 5.5 kg over the course of the program which has been recognised by the American Diabetes Association (ADA), claimed by the company in a statement.

"We have been impressed by how quickly Breathe Well-being is becoming a household name for type 2 Diabetes and pre-Diabetes Reversal across tier 2 and 3 cities of India. I realised the true value of what Rohan and Aditya are building at Breathe Well-being after seeing my own mother go through the program and reduce her HbA1c levels significantly. Hence Accel invested and we continue to back them in their vision of building a Diabetes Mukt Bharat," said Radhika Ananth, vice-president, Accel.

The Gurgaon based health-tech startup was founded by Rohan Verma and Aditya in 2020 strongly believes that medication is not a long-term solution for diabetes and instead focuses on behavioural and lifestyle changes for Diabetes reversal and reducing the risk of chronic lifestyle diseases.

Teena Jose

News Desk Reporter with Entrepreneur India

Teena is a post graduate in financial journalism. She has an avid interest in content creation, digital media and fashion.
Business Models

3 Business Models That Will Shape the Future of Entrepreneurship in 2025 and Beyond

This article helps entrepreneurs to understand how they can improve business using AI and other models for growing their business.

Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2025.

Starting a Business

He Immigrated to the U.S. and Started a Business. It's 'Not the Sexiest' But Sells Over 6,000 Units Daily — Up to $25,000 Apiece — Anyway.

When 16-year-old Amir Loloi emigrated from Iran, he didn't intend to stay in the U.S. forever. Then those plans changed.

News and Trends

Recur Club Announces Credit Offerings for Startups Beyond Series A and SMEs

In FY 24–25, the platform also plans to deploy an additional INR 2000 crores through its Recur Swift program for startups.

Innovation

7 Ways AI Made My Work Smarter — and Not Harder

AI helps me optimize operations, accelerate creativity and build more efficient teams.

News and Trends

Tata Electronics Acquires 60% Stake in Pegatron Technology India

As part of the agreement, TEPL and PTI will integrate their operations and teams to create a seamless and collaborative ecosystem. The transition will also see PTI undergo a rebranding process to reflect its new ownership and strategic direction.